Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone

被引：14

作者：

Berry, C ^{[1
]}

McMurray, J ^{[1
]}

机构：

[1] Univ Glasgow, Dept Med & Therapeut, Glasgow G12 8QQ, Lanark, Scotland

来源：

AMERICAN JOURNAL OF MEDICINE | 2001年 / 111卷 / 07期

关键词：

D O I：

10.1016/S0002-9343(01)00927-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：587 / 587

页数：1

相关论文

共 5 条

[1] Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8
[2] CONSEQUENCES OF FLUID LOSS IN PATIENTS TREATED WITH ACE INHIBITORS
MCMURRAY, J
MATTHEWS, DM
[J]. POSTGRADUATE MEDICAL JOURNAL, 1987, 63 (739) : 385 - 387
[3] Pitt B, 1996, AM J CARDIOL, V78, P902
[4] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Pitt, B
Zannad, F
Remme, WJ
Cody, R
Castaigne, A
Perez, A
Palensky, J
Wittes, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
[5] Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases
Schepkens, H
Vanholder, R
Billiouw, JM
Lameire, N
[J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (06) : 438 - 441